Sanofi (SNY) Net Income (2009 - 2025)

Sanofi (SNY) posted Net Income of $30.4 million for Q1 2026, up 100.91% sequentially from -$3.3 billion in Q4 2025, and down 83.37% YoY from $183.0 million in Q1 2025.

Sanofi (SNY) Net Income (2009 - 2025) Analysis & Trends

Sanofi (SNY) has 18 years of Net Income data on file, last reported at $30.4 million in Q1 2026.

  • Quarterly Net Income fell 83.37% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 3539.21% YoY) and the FY2025 annual result came in at $3.3 billion, up 4791.73% from the prior year.
  • Net Income grew to $30.4 million in Q1 2026 per SNY's latest filing, from -$3.3 billion in the prior quarter.
  • The five-year high for Net Income was $20.0 billion in Q4 2022, with the low at -$3.3 billion in Q4 2025.
  • Average Net Income over 5 years is $6.3 billion, with a median of $3.1 billion recorded in 2025.
  • The widest YoY moves for Net Income: up 7513.84% in 2025, down 1655.15% in 2025.
  • Sanofi's Net Income stood at $20.0 billion in 2022, then slumped by 102.36% to -$472.3 million in 2023, then soared by 59.73% to -$190.2 million in 2024, then sank by 1655.15% to -$3.3 billion in 2025, then jumped by 100.91% to $30.4 million in 2026.
  • Business Quant data shows SNY's Net Income at $30.4 million in Q1 2026, -$3.3 billion in Q4 2025, and $3.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.40 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 5.24 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 697.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 833.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -4.21 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.02 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -13.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.34 Bn
Jun 30, 2025 3.06 Bn
Dec 31, 2024 -190.21 Mn
Jun 30, 2024 48.46 Mn
Dec 31, 2023 -472.34 Mn
Jun 30, 2023 13.50 Bn
Dec 31, 2022 21.99 Bn
Jun 30, 2022 13.45 Bn
Dec 31, 2021 289.88 Mn
Jun 30, 2021 12.61 Bn
Dec 31, 2020 1.30 Bn
Jun 30, 2020 8.38 Bn
Dec 31, 2019 -2.21 Mn
Jun 30, 2019 3.18 Bn
Dec 31, 2018 324.16 Mn
Jun 30, 2018 8.89 Bn
Dec 31, 2017 -3.53 Mn
Jun 30, 2017 -7.14 Bn
Dec 31, 2016 3.69
Jun 30, 2016 -5.77 Bn